Survival Analysis of 1140 Patients with Biliary Cancer and Benefit from Concurrent Renin-Angiotensin Antagonists, Statins, or Aspirin with Systemic Therapy

BACKGROUND: Patients with advanced biliary tract cancers (BTCs) have poor prognoses and limited therapeutic options. Renin-angiotensin antagonists (ACE-I/ARBs), statins, and aspirin may have potential anti-tumorigenic effects and decrease mortality per retrospective analyses in some solid tumors. OB...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunchick, Valerie, McDevitt, Rachel L, Choi, Elizabeth, Winslow, Katherine, Zalupski, Mark M, Sahai, Vaibhav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Hepatobiliary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243793/
https://www.ncbi.nlm.nih.gov/pubmed/37036699
http://dx.doi.org/10.1093/oncolo/oyad063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243793/
https://www.ncbi.nlm.nih.gov/pubmed/37036699
http://dx.doi.org/10.1093/oncolo/oyad063

Ejemplares similares